While targeting activin A or ALK2 may serve as promising therapies to prevent ectopic bone formation in FOP, ALK2 is expressed in various cells throughout the body [97], and activin A has a role in proper skeletal development and regulating immune system functioning [98,99,100]. Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.